D. Altieri
Molecular Biology · 2000–2021
A researcher in the Science corpus: 5 papers; trusts 20 researchers and is trusted by 9 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 34 citations into it; #4,548 of 17,773 by trust here, #9,476 by citations
- Oncology — 23 citations into it; #243 of 1,698 by trust here, #1,285 by citations
- Immunology — 7 citations into it
- Cancer Research — 6 citations into it
Whom D. Altieri trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- G. Salvesen
- Yigong Shi
- X. Wang
- G. Evan
- Suzanne Cory
- Bert Vogelstein
- D. Hanahan
- J. Turkson
- A. Citri
- P. Meier
Who trusts D. Altieri overall
- Simone Fulda
- David K. Johnson
- L. Galluzzi
- Piero Dalerba
- John Karanicolas
- Ilio Vitale
- Stephen W. Fesik
- Olaf Sporns
Papers from D. Altieri's perspective
Ordered by how strongly the researchers D. Altieri trusts endorse each paper. Same corpus, a different order for every researcher.
- The Bcl2 family: regulators of the cellular life-or-death switch (Nature Reviews. Cancer)
- The expanding role of mitochondria in apoptosis. (Genes & Development)
- BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. (Genes & Development)
- Mechanisms of caspase activation and inhibition during apoptosis. (Molecules and Cells)
- Proliferation, cell cycle and apoptosis in cancer (Nature)
- From bench to clinic with apoptosis-based therapeutic agents (Nature)
- The Hallmarks of Cancer Review
- IAP proteins: blocking the road to death's door (Nature reviews. Molecular cell biology)
- Cancer genes and the pathways they control (Nature Medicine)
- EGF–ERBB signalling: towards the systems level (Nature reviews. Molecular cell biology)
Their papers
- Angiopoietin-1 Inhibits Endothelial Cell Apoptosis via the Akt/Survivin Pathway* (2000) — 691 citations
- Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 (2021) — 3,841 citations
- Survivin, cancer networks and pathway-directed drug discovery (2008) — 1,061 citations
- Survivin, versatile modulation of cell division and apoptosis in cancer (2003) — 943 citations
- Validating survivin as a cancer therapeutic target (2003) — 1,266 citations